EQ 10MG BASE,EQ 20MG BASE,EQ 40MG BASE,EQ 80MG BASE
Yes
No
2017-Jan-08
Expired
None
None
None
No
LIPITOR
is an HMG-CoA reductase inhibitor indicated as an adjunct therapy to diet to:
•
Reduce the risk of MI, stroke, revascularization procedures, and angina in adult patients without CHD, but with multiple risk factors
•
Reduce the risk of MI and stroke in adult patients with type 2 diabetes without CHD, but with multiple risk factors
•
Reduce the risk of non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for CHF, and angina in adult patients with CHD
•
Reduce elevated total-C, LDL-C, apo B, and TG levels and increase HDL-C in adult patients with primary hyperlipidemia (heterozygous familial and nonfamilial) and mixed dyslipidemia
•
Reduce elevated TG in adult patients with hypertriglyceridemia and primary dysbetalipoproteinemia
•
Reduce total-C and LDL-C in patients with homozygous familial hypercholesterolemia (HoFH)
•
Reduce elevated total-C, LDL-C, and apo B levels in pediatric patients, 10 years to 17 years of age, with heterozygous familial hypercholesterolemia (HeFH) after failing an adequate trial of diet therapy.
